Zhejiang Xinguang Pharmaceutical Hits Day Low Amid Price Pressure at CNY 14.04

Zhejiang Xinguang Pharmaceutical Co., Ltd. experienced a significant decline in its stock performance today, with a drop of 7.7% as of March 23, 2026. The stock reached an intraday low of CNY 14.04, reflecting ongoing challenges in the market. Over the past week, the company has seen a decrease of 13.56%, while its one-month performance shows a decline of 13.88%. In comparison to the broader market, represented by the China Shanghai Composite, which fell by 3.63% today, Zhejiang Xinguang's performance indicates a notable underperformance. Year-to-date, the stock is down 5.03%, contrasting with the composite's decline of 3.92%. Financial metrics reveal a market capitalization of CNY 1,623 million, categorizing it as a small-cap company. The price-to-earnings ratio stands at 44.00, and the return on equity is reported at 7.00%. Despite a dividend yield of 2.96%, the company has faced challenges with net sales growth and operating profit over the past five years, which have declined at annual rates of 2.33% and 17.63%, respectively.